Chen Ying-Hwa, Huang Shao-Sung, Lin Shing-Jong
Department of Medicine, National Yang-Ming University.
Division of Cardiology, Department of Internal Medicine.
Acta Cardiol Sin. 2018 Jan;34(1):4-12. doi: 10.6515/ACS.201801_34(1).20170730B.
Little is known about the long-term prognostic values of both thrombolysis in myocardial infarction (TIMI) and Global Registry of Acute Cardiac Events (GRACE) risk scores (RSs) to the Asian ethnicity. The purpose of this study is to compare the usefulness of these two scores in risk stratification and prediction of long-term (up to 3 years) outcomes for Chinese patients with myocardial infarction (MI).
We calculated the TIMI and GRACE RSs for 726 consecutive patients with MI [55.6% with ST-segment elevation (STEMI) and 44.4% with non-ST-segment elevation (NSTEMI)].
Although the risk profile of our population (median TIMI score = 5 for STEMI, 4 for NSTEMI, and median GRACE score = 164) was higher, the in-hospital mortality (7.1% for NSTEMI and 6.7% for STEMI) was comparable to that predicted by GRACE RS. The GRACE RS worked well in predicting short-term and long-term death (C-statistics range 0.710 to 0.789) and triple (death, MI, and stroke) endpoints (C-statistics range 0.695 to 0.764) in both subsets of MI. GRACE RS performed significantly better than the TIMIRS in predicting 3-year mortality in NSTEMI (p = 0.035) and 1-year and 3-year mortality in STEMI (p = 0.028 and 0.009, respectively). Stratification by tertiles of GRACERS furnished greater prognostic information versus risk assessment by the TIMI RS.
The use of RSs revealed a fair to good discriminatory accuracy in predicting both short-term and long-term major adverse cardiac events in Asian patients with MI. Compared with the simpler TIMI RS, the GRACERS was more accurate in predicting long-term mortality.
关于心肌梗死溶栓治疗(TIMI)风险评分和全球急性心脏事件注册研究(GRACE)风险评分对亚洲人群的长期预后价值,人们了解甚少。本研究的目的是比较这两种评分在对中国心肌梗死(MI)患者进行风险分层及预测长期(长达3年)预后方面的有用性。
我们计算了726例连续MI患者的TIMI和GRACE风险评分[55.6%为ST段抬高型心肌梗死(STEMI),44.4%为非ST段抬高型心肌梗死(NSTEMI)]。
尽管我们研究人群的风险特征较高(STEMI的TIMI评分中位数为5,NSTEMI为4,GRACE评分中位数为164),但其院内死亡率(NSTEMI为7.1%,STEMI为6.7%)与GRACE风险评分预测的死亡率相当。GRACE风险评分在预测MI两个亚组的短期和长期死亡(C统计量范围为0.710至0.789)以及三联(死亡、MI和卒中)终点(C统计量范围为0.695至0.764)方面表现良好。在预测NSTEMI的3年死亡率(p = 0.035)以及STEMI的1年和3年死亡率(分别为p = 0.028和0.009)方面,GRACE风险评分显著优于TIMI风险评分。与TIMI风险评分进行风险评估相比,按GRACE风险评分三分位数分层可提供更多的预后信息。
风险评分在预测亚洲MI患者的短期和长期主要不良心脏事件方面显示出中等至良好的鉴别准确性。与更简单的TIMI风险评分相比,GRACE风险评分在预测长期死亡率方面更准确。